LumiraDx make diagnostic-led care simpler and more accessible with smarter connected diagnostics and diagnostic-led care solutions, to enable better outcomes: better health, better experiences and better value.
The LumiraDx INR Test measures prothrombin time reported as International Normalized Ratio (INR) from a single, direct fingerstick blood sample. The Test is used for monitoring patients on oral anticoagulation therapy with Vitamin-K Antagonist (VKA) drugs. Used with the LumiraDx Instrument, the Test delivers rapid results at the point of care
Test Benefits:
INR is the preferred test for monitoring patients on vitamin K antagonist (VKA) therapy. The current standard method for monitoring INR is laboratory testing. However, the LumiraDx INR Test is performed at the point of care, which provides several benefits over laboratory testing.
- Improved convenience – on the spot testing – at the patient’s side
- Faster turnaround times when compared to laboratory testing – results in less than 90 seconds*
- Faster diagnosis and management of treatment leads to improved clinical outcomes
- Reduced number of referrals – reducing the burden upon secondary care
- Precise & accurate – CVs <5% and correlation with the Instrumentation Laboratory ACL Elite laboratory reference method
- Room temperature Test Strip storage
* Supratherapeutic INR > 4.0 test result could take 90-180 seconds
Please complete the form below for more information.